CTRI/2021/12/038691Other3 期
A Double-blind, Multi-center, Multi-regional, Randomized Controlled, Phase 3 Clinical Trial toEvaluate the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed with COVID-19
Chong Kun Dang Pharmaceutical Corp0 个研究点目标入组 46 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- Other
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Patients aged greater than or equal to 18 years
- •2) Patients diagnosed with COVID-19 infection and pneumonia
- •3) Patients who have voluntarily decided to participate in the study and signed the informed consent form If a patient cannot provide consent on his or her own, informed consent by a legally authorized representative may be obtained.
排除标准
- •1) Patients with history of hypersensitivity to the study drug
- •2) Female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study
- •3) Patients who are deemed to ineligible to participate in the study for other reasons by the investigator
研究者
相似试验
终止
不适用
A Double-blind, Multi-center, Multi-regional, Randomized Controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed with COVID-19KCT0006614Chong Kun Dang586
招募中
1 期
A study to assess the efficacy and safety of tigulixostat at different doses as compared to a control drug (allopurinol) in gout patients with hyperuricemiaGout with hyperuricemiaMedDRA version: 20.0Level: PTClassification code: 10018627Term: Gout Class: 100000004861CTIS2022-501421-20-00G Chem Ltd.5,052
已完成
4 期
Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR (Quetiapine Fumarate) in Adult Patients with Acute ManiaCTRI/2009/091/000538AstraZeneca350
进行中（未招募）
1 期
An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) in Adult Patients with Acute ManiaAcut mania in subjects with bipolar I disorderMedDRA version: 9.1Level: PTClassification code 10004939Term: Bipolar I disorderEUCTR2008-007190-20-BEAstraZeneca AB350
进行中（未招募）
不适用
An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) in Adult Patients with Acute ManiaAcut mania in subjects with bipolar I disorderMedDRA version: 9.1Level: PTClassification code 10004939Term: Bipolar I disorderEUCTR2008-007190-20-DEAstraZeneca AB350